Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort.

Sarna M, Lambert SB, Sloots TP, Whiley DM, Alsaleh A, Mhango L, Bialasiewicz S, Wang D, Nissen MD, Grimwood K, Ware RS.

Thorax. 2017 Dec 15. pii: thoraxjnl-2017-210233. doi: 10.1136/thoraxjnl-2017-210233. [Epub ahead of print]

2.

Timing of First Respiratory Virus Detections in Infants: A Community-Based Birth Cohort Study.

Sarna M, Ware RS, Lambert SB, Sloots TP, Nissen MD, Grimwood K.

J Infect Dis. 2018 Jan 17;217(3):418-427. doi: 10.1093/infdis/jix599.

PMID:
29165576
3.

β-Adrenergic Signaling Impairs Antitumor CD8+ T-cell Responses to B-cell Lymphoma Immunotherapy.

Nissen MD, Sloan EK, Mattarollo SR.

Cancer Immunol Res. 2018 Jan;6(1):98-109. doi: 10.1158/2326-6066.CIR-17-0401. Epub 2017 Nov 16.

PMID:
29146881
4.

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Lam PY, Nissen MD, Mattarollo SR.

Front Immunol. 2017 Oct 23;8:1355. doi: 10.3389/fimmu.2017.01355. eCollection 2017. Review.

5.

Detection of Toscana virus from an adult traveler returning to Australia with encephalitis.

Arden KE, Heney C, Shaban B, Nimmo GR, Nissen MD, Sloots TP, Mackay IM.

J Med Virol. 2017 Oct;89(10):1861-1864. doi: 10.1002/jmv.24839. Epub 2017 May 29.

PMID:
28464308
6.

A Difficult Decision: Atypical JC Polyomavirus Encephalopathy in a Kidney Transplant Recipient.

Bialasiewicz S, Hart G, Oliver K, Agnihotri SP, Koralnik IJ, Viscidi R, Nissen MD, Sloots TP, Burke MT, Isbel NM, Burke J.

Transplantation. 2017 Jun;101(6):1461-1467. doi: 10.1097/TP.0000000000001275.

7.

The burden of community-managed acute respiratory infections in the first 2-years of life.

Sarna M, Ware RS, Sloots TP, Nissen MD, Grimwood K, Lambert SB.

Pediatr Pulmonol. 2016 Dec;51(12):1336-1346. doi: 10.1002/ppul.23480. Epub 2016 May 26.

PMID:
27228308
8.

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.

Van Der Meeren O, Peterson JT, Dionne M, Beasley R, Ebeling PR, Ferguson M, Nissen MD, Rheault P, Simpson RW, De Ridder M, Crasta PD, Miller JM, Trofa AF.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2197-2203. Epub 2016 Apr 28.

9.

Parechovirus Encephalitis and Neurodevelopmental Outcomes.

Britton PN, Dale RC, Nissen MD, Crawford N, Elliott E, Macartney K, Khandaker G, Booy R, Jones CA; PAEDS-ACE Investigators.

Pediatrics. 2016 Feb;137(2):e20152848. doi: 10.1542/peds.2015-2848. Epub 2016 Jan 20.

10.

Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study.

Torresi J, Heron LG, Qiao M, Marjason J, Chambonneau L, Bouckenooghe A, Boaz M, van der Vliet D, Wallace D, Hutagalung Y, Nissen MD, Richmond PC.

Vaccine. 2015 Sep 22;33(39):5127-34. doi: 10.1016/j.vaccine.2015.08.008. Epub 2015 Aug 13.

11.

Rapid identification of pathogens using molecular techniques.

Sloots TP, Nissen MD, Ginn AN, Iredell JR.

Pathology. 2015 Apr;47(3):191-8. doi: 10.1097/PAT.0000000000000241. Review.

PMID:
25714588
12.

Specific rolling circle amplification of low-copy human polyomaviruses BKV, HPyV6, HPyV7, TSPyV, and STLPyV.

Rockett R, Barraclough KA, Isbel NM, Dudley KJ, Nissen MD, Sloots TP, Bialasiewicz S.

J Virol Methods. 2015 Apr;215-216:17-21. doi: 10.1016/j.jviromet.2015.02.004. Epub 2015 Feb 16.

PMID:
25698464
13.

Acquisition of human polyomaviruses in the first 18 months of life.

Rockett RJ, Bialasiewicz S, Mhango L, Gaydon J, Holding R, Whiley DM, Lambert SB, Ware RS, Nissen MD, Grimwood K, Sloots TP.

Emerg Infect Dis. 2015 Feb;21(2):365-7. doi: 10.3201/eid2102.141429.

14.

Enhancing influenza diagnostics to catch a shifting target.

Whiley DM, Mackay IM, Nimmo GR, Sloots TP, Nissen MD.

Lancet Infect Dis. 2014 Oct;14(10):923. doi: 10.1016/S1473-3099(14)70916-8. No abstract available.

PMID:
25253407
15.

Detection of a divergent Parainfluenza 4 virus in an adult patient with influenza like illness using next-generation sequencing.

Bialasiewicz S, McVernon J, Nolan T, Lambert SB, Zhao G, Wang D, Nissen MD, Sloots TP.

BMC Infect Dis. 2014 May 19;14:275. doi: 10.1186/1471-2334-14-275.

16.

Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance.

Goire N, Lahra MM, Chen M, Donovan B, Fairley CK, Guy R, Kaldor J, Regan D, Ward J, Nissen MD, Sloots TP, Whiley DM.

Nat Rev Microbiol. 2014 Mar;12(3):223-9. doi: 10.1038/nrmicro3217. Epub 2014 Feb 10. Review.

PMID:
24509781
17.

Epidemiology of respiratory viral infections in children enrolled in a study of influenza vaccine effectiveness.

Dierig A, Heron LG, Lambert SB, Yin JK, Leask J, Chow MY, Sloots TP, Nissen MD, Ridda I, Booy R.

Influenza Other Respir Viruses. 2014 May;8(3):293-301. doi: 10.1111/irv.12229. Epub 2014 Jan 31.

18.

High-throughput informative single nucleotide polymorphism-based typing of Neisseria gonorrhoeae using the Sequenom MassARRAY iPLEX platform.

Trembizki E, Smith H, Lahra MM, Chen M, Donovan B, Fairley CK, Guy R, Kaldor J, Regan D, Ward J, Nissen MD, Sloots TP, Whiley DM.

J Antimicrob Chemother. 2014 Jun;69(6):1526-32. doi: 10.1093/jac/dkt544. Epub 2014 Jan 26.

PMID:
24468863
19.

Nasal swab samples and real-time polymerase chain reaction assays in community-based, longitudinal studies of respiratory viruses: the importance of sample integrity and quality control.

Alsaleh AN, Whiley DM, Bialasiewicz S, Lambert SB, Ware RS, Nissen MD, Sloots TP, Grimwood K.

BMC Infect Dis. 2014 Jan 9;14:15. doi: 10.1186/1471-2334-14-15.

20.

Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age.

Nolan TM, Nissen MD, Naz A, Shepard J, Bedell L, Hohenboken M, Odrljin T, Dull PM.

Hum Vaccin Immunother. 2014;10(2):280-9. doi: 10.4161/hv.27051. Epub 2013 Nov 12.

21.

Screening for H7N9 influenza A by matrix gene-based real-time reverse-transcription PCR.

Hackett H, Bialasiewicz S, Jacob K, Bletchly C, Harrower B, Nimmo GR, Nissen MD, Sloots TP, Whiley DM.

J Virol Methods. 2014 Jan;195:123-5. doi: 10.1016/j.jviromet.2013.10.016. Epub 2013 Oct 14.

PMID:
24134942
22.

Bordetella holmesii and pertussis diagnosis: authors' reply.

Cox HC, Jacob K, Whiley DM, Bletchly C, Nimmo GR, Nissen MD, Sloots TP.

Pathology. 2013 Aug;45(5):532. doi: 10.1097/PAT.0b013e3283639c0d. No abstract available.

PMID:
23842047
23.

Detection of novel polyomaviruses, TSPyV, HPyV6, HPyV7, HPyV9 and MWPyV in feces, urine, blood, respiratory swabs and cerebrospinal fluid.

Rockett RJ, Sloots TP, Bowes S, O'Neill N, Ye S, Robson J, Whiley DM, Lambert SB, Wang D, Nissen MD, Bialasiewicz S.

PLoS One. 2013 May 8;8(5):e62764. doi: 10.1371/journal.pone.0062764. Print 2013.

24.

Potential animal and environmental sources of Q fever infection for humans in Queensland.

Tozer SJ, Lambert SB, Strong CL, Field HE, Sloots TP, Nissen MD.

Zoonoses Public Health. 2014 Mar;61(2):105-12. doi: 10.1111/zph.12051. Epub 2013 May 10.

PMID:
23663407
25.

Direct urine polymerase chain reaction for chlamydia and gonorrhoea: a simple means of bringing high-throughput rapid testing to remote settings?

Rahimi F, Goire N, Guy R, Kaldor JM, Ward J, Nissen MD, Sloots TP, Whiley DM.

Sex Health. 2013 Aug;10(4):299-304. doi: 10.1071/SH12108.

PMID:
23639791
26.

Polymerase chain reaction-based screening for the ceftriaxone-resistant Neisseria gonorrhoeae F89 strain.

Goire N, Lahra MM, Ohnishi M, Hogan T, Liminios AE, Nissen MD, Sloots TP, Whiley DM.

Euro Surveill. 2013 Apr 4;18(14):20444.

27.

Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents.

Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH.

Influenza Other Respir Viruses. 2013 Sep;7(5):676-85. doi: 10.1111/irv.12107. Epub 2013 Apr 2.

28.

High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform.

Syrmis MW, Moser RJ, Kidd TJ, Hunt P, Ramsay KA, Bell SC, Wainwright CE, Grimwood K, Nissen MD, Sloots TP, Whiley DM.

J Med Microbiol. 2013 May;62(Pt 5):734-40. doi: 10.1099/jmm.0.055905-0. Epub 2013 Feb 14.

PMID:
23412772
29.

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults.

Marshall HS, Richmond PC, Nissen MD, Wouters A, Baber J, Jiang Q, Anderson AS, Jones TR, Harris SL, Jansen KU, Perez JL.

Vaccine. 2013 Mar 15;31(12):1569-75. doi: 10.1016/j.vaccine.2013.01.021. Epub 2013 Jan 24.

PMID:
23352429
30.

Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness.

Ferguson PE, Gilroy NM, Faux CE, Mackay IM, Sloots TP, Nissen MD, Dwyer DE, Sorrell TC.

J Clin Virol. 2013 Mar;56(3):255-9. doi: 10.1016/j.jcv.2012.11.010. Epub 2013 Jan 3.

PMID:
23290385
31.

Further evidence that the IS481 target is suitable for real-time PCR detection of Bordetella pertussis.

Cox HC, Jacob K, Whiley DM, Bletchly C, Nimmo GR, Nissen MD, Sloots TP.

Pathology. 2013 Feb;45(2):202-3. doi: 10.1097/PAT.0b013e32835cc2d7. No abstract available.

PMID:
23277179
32.

Observational Research in Childhood Infectious Diseases (ORChID): a dynamic birth cohort study.

Lambert SB, Ware RS, Cook AL, Maguire FA, Whiley DM, Bialasiewicz S, Mackay IM, Wang D, Sloots TP, Nissen MD, Grimwood K.

BMJ Open. 2012 Oct 31;2(6). pii: e002134. doi: 10.1136/bmjopen-2012-002134. Print 2012.

33.

A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents.

Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, Jansen KU, Perez JL.

Pediatr Infect Dis J. 2013 Apr;32(4):364-71. doi: 10.1097/INF.0b013e31827b0d24.

PMID:
23114369
34.

The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance.

Goire N, Freeman K, Lambert SB, Nimmo GR, Limnios AE, Lahra MM, Nissen MD, Sloots TP, Whiley DM.

Sex Health. 2012 Nov;9(5):422-9. doi: 10.1071/SH12026.

PMID:
23036167
35.

Real-time PCR genotyping of Neisseria gonorrhoeae isolates using 14 informative single nucleotide polymorphisms on gonococcal housekeeping genes.

Whiley DM, Goire N, Rahimi F, Lahra MM, Limnios AE, Nissen MD, Sloots TP.

J Antimicrob Chemother. 2013 Feb;68(2):322-8. doi: 10.1093/jac/dks381. Epub 2012 Sep 21.

PMID:
23002175
36.

A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial.

Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, Gruber WC, Jones TR, Arora A.

Vaccine. 2012 Sep 21;30(43):6163-74. doi: 10.1016/j.vaccine.2012.07.065. Epub 2012 Aug 5.

PMID:
22871351
37.

Community-wide, contemporaneous circulation of a broad spectrum of human rhinoviruses in healthy Australian preschool-aged children during a 12-month period.

Mackay IM, Lambert SB, Faux CE, Arden KE, Nissen MD, Sloots TP, Nolan TM.

J Infect Dis. 2013 May 1;207(9):1433-41. doi: 10.1093/infdis/jis476. Epub 2012 Jul 24.

PMID:
22829638
38.

Protocol for the molecular detection of antibiotic resistance mechanisms in Neisseria gonorrhoeae.

Goire N, Sloots TP, Nissen MD, Whiley DM.

Methods Mol Biol. 2012;903:319-28. doi: 10.1007/978-1-61779-937-2_22.

PMID:
22782829
39.

Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial.

Marshall HS, Richmond PC, Nissen MD, Jiang Q, Anderson AS, Jansen KU, Reynolds G, Ziegler JB, Harris SL, Jones TR, Perez JL.

Pediatr Infect Dis J. 2012 Oct;31(10):1061-8.

PMID:
22718089
40.

The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.

Whiley DM, Goire N, Lahra MM, Donovan B, Limnios AE, Nissen MD, Sloots TP.

J Antimicrob Chemother. 2012 Sep;67(9):2059-61. doi: 10.1093/jac/dks188. Epub 2012 May 17. Review.

PMID:
22604449
41.

Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004.

Mackay IM, Arden KE, Speicher DJ, O'Neil NT, McErlean PK, Greer RM, Nissen MD, Sloots TP.

Viruses. 2012 Apr;4(4):637-53. doi: 10.3390/v4040637. Epub 2012 Apr 23.

42.

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.

Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; 2001 Study Investigators.

Lancet Infect Dis. 2012 Aug;12(8):597-607. Epub 2012 May 7.

PMID:
22569484
43.

Improved detection of genetic markers of antimicrobial resistance by hybridization probe-based melting curve analysis using primers to mask proximal mutations: examples include the influenza H275Y substitution.

Whiley DM, Jacob K, Nakos J, Bletchly C, Nimmo GR, Nissen MD, Sloots TP.

J Antimicrob Chemother. 2012 Jun;67(6):1375-9. doi: 10.1093/jac/dks040. Epub 2012 Feb 14.

PMID:
22334604
44.

Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain.

Goire N, Ohnishi M, Limnios AE, Lahra MM, Lambert SB, Nimmo GR, Nissen MD, Sloots TP, Whiley DM.

J Antimicrob Chemother. 2012 Apr;67(4):902-5. doi: 10.1093/jac/dkr549. Epub 2011 Dec 29.

PMID:
22207596
45.

Community-associated methicillin-resistant Staphylococcus aureus causing orbital cellulitis in Australian children.

Vaska VL, Grimwood K, Gole GA, Nimmo GR, Paterson DL, Nissen MD.

Pediatr Infect Dis J. 2011 Nov;30(11):1003-6. doi: 10.1097/INF.0b013e318224fda5.

PMID:
21681121
46.

Pilot study of influenza vaccine effectiveness in urban Australian children attending childcare.

Yin JK, Lahra MM, Iskander M, Lambert SB, Heron L, Nissen MD, Rost L, Murphy J, Sloots TP, Booy R.

J Paediatr Child Health. 2011 Dec;47(12):857-62. doi: 10.1111/j.1440-1754.2011.02098.x. Epub 2011 Jun 10.

PMID:
21658144
47.

False-negative results using Neisseria gonorrhoeae porA pseudogene PCR - a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011.

Whiley DM, Limnios A, Moon NJ, Gehrig N, Goire N, Hogan T, Lam A, Jacob K, Lambert SB, Nissen MD, Sloots TP.

Euro Surveill. 2011 May 26;16(21). pii: 19874.

48.

Comparison of a multiplexed MassARRAY system with real-time allele-specific PCR technology for genotyping of methicillin-resistant Staphylococcus aureus.

Syrmis MW, Moser RJ, Whiley DM, Vaska V, Coombs GW, Nissen MD, Sloots TP, Nimmo GR.

Clin Microbiol Infect. 2011 Dec;17(12):1804-10. doi: 10.1111/j.1469-0691.2011.03521.x. Epub 2011 May 20.

49.

Evaluation of a clinical scoring system and directed laboratory testing for respiratory virus infection in hematopoietic stem cell transplant recipients.

Ferguson PE, Gilroy NM, Sloots TP, Nissen MD, Dwyer DE, Sorrell TC.

Transpl Infect Dis. 2011 Oct;13(5):448-55. doi: 10.1111/j.1399-3062.2011.00631.x. Epub 2011 Apr 18.

PMID:
21501357
50.

Q fever seroprevalence in metropolitan samples is similar to rural/remote samples in Queensland, Australia.

Tozer SJ, Lambert SB, Sloots TP, Nissen MD.

Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1287-93. doi: 10.1007/s10096-011-1225-y. Epub 2011 Apr 16.

PMID:
21499708

Supplemental Content

Loading ...
Support Center